TrialCell reports. Medicine2025

Tegileridine for moderate-to-severe acute pain following abdominal surgery: A randomized, double-blind, phase 3 clinical trial.

Tingting Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.